Highlights
The global Cardiopulmonary Stress Testing Devices market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Cardiopulmonary Stress Testing Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cardiopulmonary Stress Testing Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Cardiopulmonary Stress Testing Devices include Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft), Becton, Dickinson and Company (CareFusion Corp.), COSMED, GE Healthcare, Hill-Rom, Inc. (Welch Allyn, Inc.), Nihon Kohden Corporation, Philips Healthcare, Schiller AG and OSI Systems, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Stress Testing Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Stress Testing Devices.
The Cardiopulmonary Stress Testing Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cardiopulmonary Stress Testing Devices market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Stress Testing Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft)
Becton, Dickinson and Company (CareFusion Corp.)
COSMED
GE Healthcare
Hill-Rom, Inc. (Welch Allyn, Inc.)
Nihon Kohden Corporation
Philips Healthcare
Schiller AG
OSI Systems
SunTech Medical, Inc.
Vyaire Medical, Inc.
Segment by Type
Cardiopulmonary Exercise Testing (CPET/CPEx) Monitors
Pulse Oximeter Monitors
Single-Photon Emission Computed Tomography (SPECT Or SPET)
Stress Blood Pressure Monitors
Stress Electrocardiography (ECG) Monitors
Segment by Application
Ambulatory Surgical Centers
Hospitals
Specialty Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Stress Testing Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Stress Testing Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Cardiopulmonary Stress Testing Devices Market Overview
1.1 Product Overview and Scope of Cardiopulmonary Stress Testing Devices
1.2 Cardiopulmonary Stress Testing Devices Segment by Type
1.2.1 Global Cardiopulmonary Stress Testing Devices Market Value Comparison by Type (2023-2029)
1.2.2 Cardiopulmonary Exercise Testing (CPET/CPEx) Monitors
1.2.3 Pulse Oximeter Monitors
1.2.4 Single-Photon Emission Computed Tomography (SPECT Or SPET)
1.2.5 Stress Blood Pressure Monitors
1.2.6 Stress Electrocardiography (ECG) Monitors
1.3 Cardiopulmonary Stress Testing Devices Segment by Application
1.3.1 Global Cardiopulmonary Stress Testing Devices Market Value by Application: (2023-2029)
1.3.2 Ambulatory Surgical Centers
1.3.3 Hospitals
1.3.4 Specialty Clinics
1.4 Global Cardiopulmonary Stress Testing Devices Market Size Estimates and Forecasts
1.4.1 Global Cardiopulmonary Stress Testing Devices Revenue 2018-2029
1.4.2 Global Cardiopulmonary Stress Testing Devices Sales 2018-2029
1.4.3 Global Cardiopulmonary Stress Testing Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cardiopulmonary Stress Testing Devices Market Competition by Manufacturers
2.1 Global Cardiopulmonary Stress Testing Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cardiopulmonary Stress Testing Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cardiopulmonary Stress Testing Devices Average Price by Manufacturers (2018-2023)
2.4 Global Cardiopulmonary Stress Testing Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cardiopulmonary Stress Testing Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Stress Testing Devices, Product Type & Application
2.7 Cardiopulmonary Stress Testing Devices Market Competitive Situation and Trends
2.7.1 Cardiopulmonary Stress Testing Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiopulmonary Stress Testing Devices Players Market Share by Revenue
2.7.3 Global Cardiopulmonary Stress Testing Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiopulmonary Stress Testing Devices Retrospective Market Scenario by Region
3.1 Global Cardiopulmonary Stress Testing Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cardiopulmonary Stress Testing Devices Global Cardiopulmonary Stress Testing Devices Sales by Region: 2018-2029
3.2.1 Global Cardiopulmonary Stress Testing Devices Sales by Region: 2018-2023
3.2.2 Global Cardiopulmonary Stress Testing Devices Sales by Region: 2024-2029
3.3 Global Cardiopulmonary Stress Testing Devices Global Cardiopulmonary Stress Testing Devices Revenue by Region: 2018-2029
3.3.1 Global Cardiopulmonary Stress Testing Devices Revenue by Region: 2018-2023
3.3.2 Global Cardiopulmonary Stress Testing Devices Revenue by Region: 2024-2029
3.4 North America Cardiopulmonary Stress Testing Devices Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Stress Testing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cardiopulmonary Stress Testing Devices Sales by Country (2018-2029)
3.4.3 North America Cardiopulmonary Stress Testing Devices Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Stress Testing Devices Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Stress Testing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cardiopulmonary Stress Testing Devices Sales by Country (2018-2029)
3.5.3 Europe Cardiopulmonary Stress Testing Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Stress Testing Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiopulmonary Stress Testing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cardiopulmonary Stress Testing Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Cardiopulmonary Stress Testing Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cardiopulmonary Stress Testing Devices Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Stress Testing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cardiopulmonary Stress Testing Devices Sales by Country (2018-2029)
3.7.3 Latin America Cardiopulmonary Stress Testing Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Stress Testing Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Stress Testing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cardiopulmonary Stress Testing Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cardiopulmonary Stress Testing Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiopulmonary Stress Testing Devices Sales by Type (2018-2029)
4.1.1 Global Cardiopulmonary Stress Testing Devices Sales by Type (2018-2023)
4.1.2 Global Cardiopulmonary Stress Testing Devices Sales by Type (2024-2029)
4.1.3 Global Cardiopulmonary Stress Testing Devices Sales Market Share by Type (2018-2029)
4.2 Global Cardiopulmonary Stress Testing Devices Revenue by Type (2018-2029)
4.2.1 Global Cardiopulmonary Stress Testing Devices Revenue by Type (2018-2023)
4.2.2 Global Cardiopulmonary Stress Testing Devices Revenue by Type (2024-2029)
4.2.3 Global Cardiopulmonary Stress Testing Devices Revenue Market Share by Type (2018-2029)
4.3 Global Cardiopulmonary Stress Testing Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cardiopulmonary Stress Testing Devices Sales by Application (2018-2029)
5.1.1 Global Cardiopulmonary Stress Testing Devices Sales by Application (2018-2023)
5.1.2 Global Cardiopulmonary Stress Testing Devices Sales by Application (2024-2029)
5.1.3 Global Cardiopulmonary Stress Testing Devices Sales Market Share by Application (2018-2029)
5.2 Global Cardiopulmonary Stress Testing Devices Revenue by Application (2018-2029)
5.2.1 Global Cardiopulmonary Stress Testing Devices Revenue by Application (2018-2023)
5.2.2 Global Cardiopulmonary Stress Testing Devices Revenue by Application (2024-2029)
5.2.3 Global Cardiopulmonary Stress Testing Devices Revenue Market Share by Application (2018-2029)
5.3 Global Cardiopulmonary Stress Testing Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft)
6.1.1 Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft) Corporation Information
6.1.2 Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft) Description and Business Overview
6.1.3 Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft) Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft) Cardiopulmonary Stress Testing Devices Product Portfolio
6.1.5 Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft) Recent Developments/Updates
6.2 Becton, Dickinson and Company (CareFusion Corp.)
6.2.1 Becton, Dickinson and Company (CareFusion Corp.) Corporation Information
6.2.2 Becton, Dickinson and Company (CareFusion Corp.) Description and Business Overview
6.2.3 Becton, Dickinson and Company (CareFusion Corp.) Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Becton, Dickinson and Company (CareFusion Corp.) Cardiopulmonary Stress Testing Devices Product Portfolio
6.2.5 Becton, Dickinson and Company (CareFusion Corp.) Recent Developments/Updates
6.3 COSMED
6.3.1 COSMED Corporation Information
6.3.2 COSMED Description and Business Overview
6.3.3 COSMED Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 COSMED Cardiopulmonary Stress Testing Devices Product Portfolio
6.3.5 COSMED Recent Developments/Updates
6.4 GE Healthcare
6.4.1 GE Healthcare Corporation Information
6.4.2 GE Healthcare Description and Business Overview
6.4.3 GE Healthcare Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GE Healthcare Cardiopulmonary Stress Testing Devices Product Portfolio
6.4.5 GE Healthcare Recent Developments/Updates
6.5 Hill-Rom, Inc. (Welch Allyn, Inc.)
6.5.1 Hill-Rom, Inc. (Welch Allyn, Inc.) Corporation Information
6.5.2 Hill-Rom, Inc. (Welch Allyn, Inc.) Description and Business Overview
6.5.3 Hill-Rom, Inc. (Welch Allyn, Inc.) Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hill-Rom, Inc. (Welch Allyn, Inc.) Cardiopulmonary Stress Testing Devices Product Portfolio
6.5.5 Hill-Rom, Inc. (Welch Allyn, Inc.) Recent Developments/Updates
6.6 Nihon Kohden Corporation
6.6.1 Nihon Kohden Corporation Corporation Information
6.6.2 Nihon Kohden Corporation Description and Business Overview
6.6.3 Nihon Kohden Corporation Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nihon Kohden Corporation Cardiopulmonary Stress Testing Devices Product Portfolio
6.6.5 Nihon Kohden Corporation Recent Developments/Updates
6.7 Philips Healthcare
6.6.1 Philips Healthcare Corporation Information
6.6.2 Philips Healthcare Description and Business Overview
6.6.3 Philips Healthcare Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Philips Healthcare Cardiopulmonary Stress Testing Devices Product Portfolio
6.7.5 Philips Healthcare Recent Developments/Updates
6.8 Schiller AG
6.8.1 Schiller AG Corporation Information
6.8.2 Schiller AG Description and Business Overview
6.8.3 Schiller AG Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Schiller AG Cardiopulmonary Stress Testing Devices Product Portfolio
6.8.5 Schiller AG Recent Developments/Updates
6.9 OSI Systems
6.9.1 OSI Systems Corporation Information
6.9.2 OSI Systems Description and Business Overview
6.9.3 OSI Systems Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 OSI Systems Cardiopulmonary Stress Testing Devices Product Portfolio
6.9.5 OSI Systems Recent Developments/Updates
6.10 SunTech Medical, Inc.
6.10.1 SunTech Medical, Inc. Corporation Information
6.10.2 SunTech Medical, Inc. Description and Business Overview
6.10.3 SunTech Medical, Inc. Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SunTech Medical, Inc. Cardiopulmonary Stress Testing Devices Product Portfolio
6.10.5 SunTech Medical, Inc. Recent Developments/Updates
6.11 Vyaire Medical, Inc.
6.11.1 Vyaire Medical, Inc. Corporation Information
6.11.2 Vyaire Medical, Inc. Cardiopulmonary Stress Testing Devices Description and Business Overview
6.11.3 Vyaire Medical, Inc. Cardiopulmonary Stress Testing Devices Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Vyaire Medical, Inc. Cardiopulmonary Stress Testing Devices Product Portfolio
6.11.5 Vyaire Medical, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Stress Testing Devices Industry Chain Analysis
7.2 Cardiopulmonary Stress Testing Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Stress Testing Devices Production Mode & Process
7.4 Cardiopulmonary Stress Testing Devices Sales and Marketing
7.4.1 Cardiopulmonary Stress Testing Devices Sales Channels
7.4.2 Cardiopulmonary Stress Testing Devices Distributors
7.5 Cardiopulmonary Stress Testing Devices Customers
8 Cardiopulmonary Stress Testing Devices Market Dynamics
8.1 Cardiopulmonary Stress Testing Devices Industry Trends
8.2 Cardiopulmonary Stress Testing Devices Market Drivers
8.3 Cardiopulmonary Stress Testing Devices Market Challenges
8.4 Cardiopulmonary Stress Testing Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Altus Capital Partners, Inc. (MGC Diagnostics Corp. / Medisoft)
Becton, Dickinson and Company (CareFusion Corp.)
COSMED
GE Healthcare
Hill-Rom, Inc. (Welch Allyn, Inc.)
Nihon Kohden Corporation
Philips Healthcare
Schiller AG
OSI Systems
SunTech Medical, Inc.
Vyaire Medical, Inc.
*If Applicable.